https://www.selleckchem.com/products/oltipraz.html
Introduction Noninvasive ventilation (NIV) has been used to alleviate hypoxemia and dyspnea, but there is no consensus on the application of NIV in patients with coronavirus disease 2019 (COVID-19). Some staff use NIV as the rescue therapy which might lead to the adverse outcomes. This study was to identify early factors associated with intubation to help the medical staff select appropriate patients for receiving NIV treatment. Methods Patients with laboratory-confirmed COVID-19 who were treated with NIV in emergency department or ICU